Singapore markets closed
Straits Times Index
3,291.87 +9.82 (+0.30%) S&P 500
5,116.17 +16.21 (+0.32%) Dow
38,386.09 +146.43 (+0.38%) Nasdaq
15,983.08 +55.18 (+0.35%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,297.59 -41.48 (-3.10%)
Coherus BioSciences, Inc. (CHRS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 234.94M |
| Enterprise value | 598.04M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.76 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 2.32 |
| Enterprise value/EBITDA | -3.08 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.51 |
| 52-week change 3 | -71.13% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 8.2200 |
| 52-week low 3 | 1.4300 |
| 50-day moving average 3 | 2.3170 |
| 200-day moving average 3 | 3.0984 |
Share statistics
| Avg vol (3-month) 3 | 2.57M |
| Avg vol (10-day) 3 | 1.46M |
| Shares outstanding 5 | 113.5M |
| Implied shares outstanding 6 | 113.5M |
| Float 8 | 103.87M |
| % held by insiders 1 | 1.41% |
| % held by institutions 1 | 77.11% |
| Shares short (15 Apr 2024) 4 | 21.53M |
| Short ratio (15 Apr 2024) 4 | 8.97 |
| Short % of float (15 Apr 2024) 4 | 22.20% |
| Short % of shares outstanding (15 Apr 2024) 4 | 18.97% |
| Shares short (prior month 15 Mar 2024) 4 | 25.91M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -92.48% |
| Operating margin (ttm) | -98.78% |
Management effectiveness
| Return on assets (ttm) | -21.75% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 257.24M |
| Revenue per share (ttm) | 2.73 |
| Quarterly revenue growth (yoy) | 101.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -189.41M |
| Net income avi to common (ttm) | -237.89M |
| Diluted EPS (ttm) | -2.5300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 117.75M |
| Total cash per share (mrq) | 1.04 |
| Total debt (mrq) | 480.84M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.43 |
| Book value per share (mrq) | -1.72 |
Cash flow statement
| Operating cash flow (ttm) | -174.88M |
| Levered free cash flow (ttm) | -70.1M |
© 2024 Yahoo. All rights reserved.